🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and how well giving autologous ...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2012-01
Trial ID
NCT01477021
Treatments Being Tested
This study, will take a subject's "T cells" and "teach" them to be able to ...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2013-07-09
Trial ID
NCT01567891
Treatments Being Tested
This phase I trial studies the best dose and side effects of NY-ESO-1 T cel...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2019-03-08
Trial ID
NCT03691376
Treatments Being Tested
This pilot, phase I trial studies the safety of cancer-testis antigen (NY-E...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-01
Trial ID
NCT02319824
This trial will evaluate safety and efficacy of human engineered T-cell the...
Status
Active Not Recruiting
Location
City of Hope National Medical Center
Start Date
2019-12-31
Trial ID
NCT03967223
Treatments Being Tested
Adoptive T-cell therapy is a therapeutic approach that aims to generate an ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-02-25
Trial ID
NCT03697824
Treatments Being Tested
The target populations for this phase I study with TBI-1301 are patients wi...
Status
Active Not Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2016-09
Trial ID
NCT02869217
Treatments Being Tested
The goal of this clinical research study is to find a recommended dose of d...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-03-27
Trial ID
NCT06083883
Treatments Being Tested
This phase I trial studies the side effects of genetically modified T cells...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Start Date
2017-12-08
Trial ID
NCT03017131
This trial will evaluate safety, tolerability, and efficacy of letetresgene...
Status
Terminated
Location
GSK Investigational Site
Start Date
2017-08-18
Trial ID
NCT03168438